Skip to main content
. 2021 Aug 13;12:691605. doi: 10.3389/fimmu.2021.691605

Figure 3.

Figure 3

A case report of Patient P01. (A) Treatment timeline of P01. (B) Comparison of lymph node before & after vaccination by imaging. (C, D) Ex vivo IFN-γ ELISpot of PBMCs was performed with peptides at different time points. The dimethyl sulfoxide (DMSO) group was used as the negative control and mixed peptides from CEF (including peptides of cytomegalovirus, Epstein–Barr virus and influenza virus) were used as the positive control. (E) Increased abundance of peripheral T cell clones after vaccination was detected by TCR sequencing.